ES530592A0 - Procedimiento para la inactivacion de sustancias que provocan reacciones de incompatibilidad en productos sanguineos - Google Patents

Procedimiento para la inactivacion de sustancias que provocan reacciones de incompatibilidad en productos sanguineos

Info

Publication number
ES530592A0
ES530592A0 ES530592A ES530592A ES530592A0 ES 530592 A0 ES530592 A0 ES 530592A0 ES 530592 A ES530592 A ES 530592A ES 530592 A ES530592 A ES 530592A ES 530592 A0 ES530592 A0 ES 530592A0
Authority
ES
Spain
Prior art keywords
blood products
substances
inactivation
procedure
cause incompatibility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES530592A
Other languages
English (en)
Other versions
ES8604990A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Immuno AG fuer Chemisch Medizinische Produkte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG, Immuno AG fuer Chemisch Medizinische Produkte filed Critical Immuno AG
Publication of ES8604990A1 publication Critical patent/ES8604990A1/es
Publication of ES530592A0 publication Critical patent/ES530592A0/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Saccharide Compounds (AREA)
  • Catalysts (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES530592A 1983-03-16 1984-03-14 Procedimiento para la inactivacion de sustancias que provocan reacciones de incompatibilidad en productos sanguineos Expired ES8604990A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0093183A AT383739B (de) 1983-03-16 1983-03-16 Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen

Publications (2)

Publication Number Publication Date
ES8604990A1 ES8604990A1 (es) 1986-04-01
ES530592A0 true ES530592A0 (es) 1986-04-01

Family

ID=3503142

Family Applications (1)

Application Number Title Priority Date Filing Date
ES530592A Expired ES8604990A1 (es) 1983-03-16 1984-03-14 Procedimiento para la inactivacion de sustancias que provocan reacciones de incompatibilidad en productos sanguineos

Country Status (8)

Country Link
US (1) US4886758A (es)
EP (1) EP0120835B1 (es)
JP (2) JPS601136A (es)
AT (2) AT383739B (es)
CA (2) CA1216792A (es)
DE (1) DE3482845D1 (es)
DK (1) DK166713B1 (es)
ES (1) ES8604990A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166763B1 (da) * 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
FR2582515B1 (fr) * 1985-05-30 1988-11-04 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
DE3609954A1 (de) * 1986-03-25 1987-10-01 Biotest Pharma Gmbh Verfahren zur herstellung eines den blutgerinnungsfaktor viii in ankonzentrierter form enthaltenden praeparates
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
AT388501B (de) * 1987-02-12 1989-07-25 Immuno Ag Verfahren zur herstellung von parenteral verabreichbaren blutprodukten
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
US5328834A (en) * 1989-09-08 1994-07-12 Unisyn Technologies, Inc. Method for preparing immunoglobulin fragments
AT396937B (de) * 1992-04-06 1993-12-27 Immuno Ag Verfahren zur aktivierung von blutgerinnungsfaktoren
EP0835880A1 (de) * 1996-10-14 1998-04-15 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
JP4830768B2 (ja) * 2006-05-10 2011-12-07 日亜化学工業株式会社 半導体発光装置及び半導体発光装置の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1148037B (de) * 1961-10-11 1963-05-02 Behringwerke Ag Verfahren zur Herstellung eines desaggregierten, das Komplementsystem nicht beeinflussenden Gammaglobulins
CH392780A (de) * 1961-12-07 1965-05-31 Schweiz Rotes Kreuz Verfahren zur Herstellung von intravenös anwendbaren Antikörperpräparaten humanen Ursprungs
AU469815B2 (en) * 1971-04-14 1973-10-18 Anti-inflammatory compositions
JPS5548392A (en) * 1978-02-17 1980-04-07 Toyo Jozo Co Ltd Novel immobilizing material combined with biologically active substance, its preparation, device comprising it, method, and preparation of support
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
DE2846412A1 (de) * 1978-10-25 1980-05-08 Behringwerke Ag Mittel zur behandlung allergischer reaktionen
JPS567721A (en) * 1979-07-02 1981-01-27 Mochida Pharmaceut Co Ltd Preparation of immunoglobulin for intravenous injection
JPS5615215A (en) * 1979-07-14 1981-02-14 Nippon Sekijiyuujishiya Preparation of human immunoglobulin for intravenous injection with immobilized pepsin gel
JPS57206608A (en) * 1981-05-29 1982-12-18 Mochida Pharmaceut Co Ltd Production of gamma-globulin for intravenous injection

Also Published As

Publication number Publication date
JPS6296857A (ja) 1987-05-06
DK166713B1 (da) 1993-07-05
EP0120835A2 (de) 1984-10-03
ATA93183A (de) 1987-01-15
JPH0585529B2 (es) 1993-12-07
AT383739B (de) 1987-08-10
DK131284D0 (da) 1984-02-29
CA1248447A (en) 1989-01-10
DE3482845D1 (de) 1990-09-06
CA1216792A (en) 1987-01-20
EP0120835A3 (en) 1986-12-30
EP0120835B1 (de) 1990-08-01
US4886758A (en) 1989-12-12
ES8604990A1 (es) 1986-04-01
ATE55059T1 (de) 1990-08-15
DK131284A (da) 1984-09-17
JPH0684965B2 (ja) 1994-10-26
JPS601136A (ja) 1985-01-07

Similar Documents

Publication Publication Date Title
DE3869490D1 (de) Verfahren zur elektrochemischen behandlung von stoffen.
DE3789625T2 (de) Methode zur dynamischen Partitionierung von Parallelprozessoren.
ATE31670T1 (de) Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material.
DE3884622T2 (de) Schmiermittelzubereitung zur behandlung von rheuma.
DE59600309D1 (de) Vorrichtung zur Behandlung von Flüssigkeiten, insbesondere von Blut
ES2032276T3 (es) Metodo para el tratamiento de plasma y productos derivados del mismo.
DE3886254T2 (de) Apparat zur Behandlung von biologischen Proben und Behandlungsmethoden mit dem Apparat.
ES530592A0 (es) Procedimiento para la inactivacion de sustancias que provocan reacciones de incompatibilidad en productos sanguineos
ATE484294T1 (de) Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen
DE3781930T2 (de) Verfahren zur behandlung von organischen abfallstoffen und dafuer nuetzliche katalysator-/co-katalysator-zusammensetzung.
DE68921229D1 (de) Prozess zur Behandlung von unlöslichem heterogenem Fusionsprotein.
DE3885460T2 (de) Vorrichtung zur behandlung von flüssigkeiten.
DE69009137T2 (de) Behandlungsverfahren zur Konservierung von frischen pflanzlichen Lebensmitteln.
DE3764284D1 (de) Behandlungsverfahren zur holzkonservierung und holzkonservierungsmittel zum verfahren.
ATE56990T1 (de) Verfahren und reagenz zur bestimmung von gesamt- bilirubin.
ES502084A0 (es) Procedimiento para tratar fracciones individuales de plasma sanguineo.
ATE124706T1 (de) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben.
DE3781279D1 (de) Verfahren zur behandlung von blut.
DE3886755T2 (de) Verfahren zur behandlung von gefässkrankheiten.
DE68908445D1 (de) Mittel zur behandlung von lebererkrankungen.
GB2011910A (en) Process for the Treatment of Proteinaceous Materials of Animal Origin
DE3579072D1 (de) Vorrichtung zur behandlung von schrammen.
DE3280419D1 (de) Medizinisches praeparat zur behandlung von hautleiden.
DE69430807T2 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
ES541333A0 (es) Procedimiento de tratamiento de residuos de caracter organi-co en presencia de sepiolita

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040601